About the project
The STOP-PKD trial is investigating a new treatment option for people with autosomal dominant polycystic kidney disease (ADPKD).
What is STOP PKD about?
This study aims to investigate whether an already approved drug from the group of so-called SGLT2 inhibitors can positively influence the course of ADPKD.